
Stryker (SYK) Stock Forecast & Price Target
Stryker (SYK) Analyst Ratings
Bulls say
Stryker is poised for above-average revenue growth driven by organic growth, acquisitions, and the Mako robotics system. Concerns about a slowdown in elective procedures, inflationary pressures, and supply shortages could temporarily drag shares, but the company's diversification and track record make it a long-term investment worth considering. Additionally, the recent introduction of the Ortho Tech segment and strong international growth potential offer upside to the company's already strong analyst consensus target price of $418.
Bears say
Stryker is expanding its product portfolio to include more diverse medical equipment, but the majority of its revenue still comes from orthopedic implants and operating room equipment. The recent cyber incident and potential for dilution in acquirements pose a risk to EPS growth. While the company has strong execution abilities, slower market growth and a potential slowdown in hospital capital spending could hinder future earnings.
This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.
Stryker (SYK) Analyst Forecast & Price Prediction
Start investing in Stryker (SYK)
Order type
Buy in
Order amount
Est. shares
0 shares